Aclidinium bromide

Details

Files

Generic Name:

Aclidinium bromide

Project Status:

Complete

Therapeutic Area:

Chronic Obstructive Pulmonary Disease

Manufacturer:

Almirall Canada Ltd.

Call for patient/clinician input open:

July 30, 2013

Brand Name:

Tudorza Genuair

Project Line:

Reimbursement Review

Project Number:

SR0346-000

Call for patient/clinician input closed:

September 13, 2013

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Chronic Obstructive Pulmonary Disease (COPD)

Recommendation Type:

List with criteria/condition

Final Recommendation:

April 21, 2014

Files

Submission Status Report View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Recommendation and Reasons View PDF

Last Updated : August 21, 2013